Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015 (2015), Article ID 365854, 12 pages
http://dx.doi.org/10.1155/2015/365854
Research Article

Luteolin Exerts Cardioprotective Effects through Improving Sarcoplasmic Reticulum Ca2+-ATPase Activity in Rats during Ischemia/Reperfusion In Vivo

1Institute of Cardiovascular Disease, Xuzhou Medical College, Xuzhou, Jiangsu 221002, China
2Department of Cardiology, The Affiliated Hospital of Xuzhou Medical College, Xuzhou, Jiangsu 221002, China

Received 22 June 2015; Revised 6 October 2015; Accepted 12 October 2015

Academic Editor: Yew-Min Tzeng

Copyright © 2015 Changsheng Nai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Fang, D. Li, H. Pan et al., “Luteolin inhibits apoptosis and improves cardiomyocyte contractile function through the PI3K/Akt pathway in simulated ischemia/reperfusion,” Pharmacology, vol. 88, no. 3-4, pp. 149–158, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. X. Wu, T. Xu, D. Li et al., “ERK/PP1a/PLB/SERCA2a and JNK Pathways are involved in luteolin-mediated protection of rat hearts and cardiomyocytes following ischemia/reperfusion,” PLoS ONE, vol. 8, no. 12, Article ID e82957, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. X. Yin, Y. Zheng, X. Zhai, X. Zhao, and L. Cai, “Diabetic inhibition of preconditioning- and postconditioning-mediated myocardial protection against ischemia/reperfusion injury,” Experimental Diabetes Research, vol. 2012, Article ID 198048, 9 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. M. A. H. Talukder, A. Kalyanasundaram, X. Zhao et al., “Expression of SERCA isoform with faster Ca2+ transport properties improves postischemic cardiac function and Ca2+ handling and decreases myocardial infarction,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 293, no. 4, pp. H2418–H2428, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Akolkar, J. Pande, S. E. Samson, and A. K. Grover, “Thapsigargin decreases the Na+-Ca2+ exchanger mediated Ca2+ entry in pig coronary artery smooth muscle,” Biochimica et Biophysica Acta, vol. 1818, no. 3, pp. 730–737, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. C. M. Misquitta, J. Mwanjewe, L. Nie, and A. K. Grover, “Sarcoplasmic reticulum Ca2+ pump mRNA stability in cardiac and smooth muscle: role of the 3′-untranslated region,” The American Journal of Physiology—Cell Physiology, vol. 283, no. 2, pp. C560–C568, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. M. A. H. Talukder, A. Kalyanasundaram, L. Zuo et al., “Is reduced SERCA2a expression detrimental or beneficial to postischemic cardiac function and injury? Evidence from heterozygous SERCA2a knockout mice,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 294, no. 3, pp. H1426–H1434, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. Y.-K. Kim, J. Suarez, Y. Hu et al., “Deletion of the inducible 70-kDa heat shock protein genes in mice impairs cardiac contractile function and calcium handling associated with hypertrophy,” Circulation, vol. 113, no. 22, pp. 2589–2597, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Qi, H. Pan, D. Li, F. Fang, D. Chen, and H. Sun, “Luteolin improves contractile function and attenuates apoptosis following ischemia-reperfusion in adult rat cardiomyocytes,” European Journal of Pharmacology, vol. 668, no. 1-2, pp. 201–207, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. E. Middleton Jr., C. Kandaswami, and T. C. Theoharides, “The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer,” Pharmacological Reviews, vol. 52, no. 4, pp. 673–751, 2000. View at Google Scholar · View at Scopus
  11. M. G. L. Hertog, E. J. M. Feskens, P. C. H. Hollman, M. B. Katan, and D. Kromhout, “Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study,” The Lancet, vol. 342, no. 8878, pp. 1007–1011, 1993. View at Publisher · View at Google Scholar · View at Scopus
  12. Y.-M. Zhang, C.-Y. Wang, F.-C. Zheng et al., “Effects of N-n-butyl haloperidol iodide on the rat myocardial sarcoplasmic reticulum Ca2+-ATPase during ischemia/reperfusion,” Biochemical and Biophysical Research Communications, vol. 425, no. 2, pp. 426–430, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Shimoi, H. Okada, M. Furugori et al., “Intestinal absorption of luteolin and luteolin 7-O-β-glucoside in rats and humans,” FEBS Letters, vol. 438, no. 3, pp. 220–224, 1998. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Chen, L.-P. Li, X.-Y. Lu, H.-D. Jiang, and Z. Su, “Absorption and excretion of luteolin and apigenin in rats after oral administration of Chrysanthemum morifolium extract,” Journal of Agricultural and Food Chemistry, vol. 55, no. 2, pp. 273–277, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. P. R. S. Kodavanti, J. A. Cameron, P. R. Yallapragada, and D. Desaiah, “Effect of chlordecone (Kepone) on calcium transport mechanisms in rat heart sarcoplasmic reticulum,” Pharmacology and Toxicology, vol. 67, no. 3, pp. 227–234, 1990. View at Publisher · View at Google Scholar · View at Scopus
  16. S. J. Smith, R. M. Evans, M. Sullivan-Fowler, and W. R. Hendee, “Use of animals in biomedical research. Historical role of the American Medical Association and the American physician,” Archives of Internal Medicine, vol. 148, no. 8, pp. 1849–1853, 1988. View at Publisher · View at Google Scholar · View at Scopus
  17. D. M. Yellon and D. J. Hausenloy, “Myocardial reperfusion injury,” The New England Journal of Medicine, vol. 357, no. 5, pp. 1121–1135, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Zhang, X. Liu, Z.-G. She et al., “Interferon regulatory factor 9 is an essential mediator of heart dysfunction and cell death following myocardial ischemia/reperfusion injury,” Basic Research in Cardiology, vol. 109, no. 5, article 434, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. H.-C. Shih, M.-S. Huang, and C.-H. Lee, “Estrogen augments the protection of hypertonic saline treatment from mesenteric ischemia-reperfusion injury,” Shock, vol. 35, no. 3, pp. 302–307, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Liu, H. Fang, O. Dirsch, H. Jin, and U. Dahmen, “Early release of macrophage migration inhibitory factor after liver ischemia and reperfusion injury in rats,” Cytokine, vol. 57, no. 1, pp. 150–157, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. C.-M. Zhang, L. Gao, Y.-J. Zheng, and H.-T. Yang, “Berbamine protects the heart from ischemia/reperfusion injury by maintaining cytosolic Ca2+ homeostasis and preventing calpain activation,” Circulation Journal, vol. 76, no. 8, pp. 1993–2002, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Wu, M. Ye, J. Yang et al., “Nicorandil protects the heart from ischemia/reperfusion injury by attenuating endoplasmic reticulum response-induced apoptosis through PI3K/Akt signaling pathway,” Cellular Physiology and Biochemistry, vol. 35, no. 6, pp. 2320–2332, 2015. View at Publisher · View at Google Scholar
  23. C. J. Mullonkal and L. H. Toledo-Pereyra, “Akt in ischemia and reperfusion,” Journal of Investigative Surgery, vol. 20, no. 3, pp. 195–203, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Li, J. Tian, G. Li et al., “Asperosaponin VI protects cardiac myocytes from hypoxia-induced apoptosis via activation of the PI3K/Akt and CREB pathways,” European Journal of Pharmacology, vol. 649, no. 1–3, pp. 100–107, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. T. Matsui, J. Tao, F. Del Monte et al., “Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo,” Circulation, vol. 104, no. 3, pp. 330–335, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. V. M. Figueredo, C. Okusa, K. Kaneda, Y. Inamura, and M. Miyamae, “Regular dipyridamole therapy produces sustained protection against cardiac ischemia-reperfusion injury: is it time to revisit PARIS?” International Journal of Cardiology, vol. 176, no. 3, pp. 822–827, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. D. Sun, J. Huang, Z. Zhang et al., “Luteolin limits infarct size and improves cardiac function after myocardium ischemia/reperfusion injury in diabetic rats,” PLoS ONE, vol. 7, no. 3, Article ID e33491, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. X.-L. Tang, J.-X. Liu, W. Dong et al., “The cardioprotective effect of protocatechuic acid on myocardial ischemia/reperfusion injury,” Journal of Pharmacological Sciences, vol. 125, no. 2, pp. 176–183, 2014. View at Publisher · View at Google Scholar · View at Scopus